litlas
Log inCreate account

William E. Gooding

Active 1987–2023

102
Papers
19,358
Citations
85
h-index
102
i10-index

Citations

Citations per year for William E. Gooding1988: 2 citations1990: 3 citations1991: 6 citations1992: 19 citations1993: 14 citations1994: 21 citations1995: 12 citations1996: 8 citations1997: 10 citations1998: 13 citations1999: 24 citations2000: 26 citations2001: 41 citations2002: 63 citations2003: 70 citations2004: 80 citations2005: 129 citations2006: 121 citations2007: 120 citations2008: 147 citations2009: 166 citations2010: 176 citations2011: 148 citations2012: 164 citations2013: 197 citations2014: 128 citations2015: 164 citations2016: 196 citations2017: 229 citations2018: 178 citations2019: 711 citations2020: 727 citations2021: 571 citations2022: 448 citations2023: 299 citations2024: 401 citations2025: 179 citations2026: 3 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,396 citing papers, 33.2% of this breakdownChina: 885 citing papers, 12.3% of this breakdownItaly: 357 citing papers, 5% of this breakdownGermany: 355 citing papers, 4.9% of this breakdownUnited Kingdom: 299 citing papers, 4.1% of this breakdownJapan: 261 citing papers, 3.6% of this breakdownCanada: 232 citing papers, 3.2% of this breakdownFrance: 215 citing papers, 3% of this breakdownAustralia: 187 citing papers, 2.6% of this breakdownSouth Korea: 170 citing papers, 2.4% of this breakdownNetherlands: 168 citing papers, 2.3% of this breakdownIndia: 146 citing papers, 2% of this breakdown
0%33.2%Other 21.4%

Institutions

Fields

  • Medicine62%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Immunology and Microbiology9.1%
  • Psychology2.2%
  • Engineering0.6%
  • Social Sciences0.6%
  • Other2%

Topics

  • Cancer Immunotherapy and Biomarkers5.3%
  • Immunotherapy and Immune Responses4.1%
  • Thyroid Cancer Diagnosis and Treatment4%
  • Head and Neck Cancer Studies3.7%
  • Extracellular vesicles in disease3.6%
  • Immune Cell Function and Interaction3.3%
  • Other76%

Coauthors

All papers

Open in search
  1. Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

    Authors: Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni, Thomas K. Hoffmann, William E. Gooding, Theresa L. Whiteside - Clinical Cancer Research 2017 cited by 615

  2. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma

    Authors: Yuri E. Nikiforov, Raja R. Seethala, Giovanni Tallini, Zubair Baloch, Fulvio Basolo, Lester D.�R. Thompson, Justine A. Barletta, Bruce M. Wenig, Abir Al Ghuzlan, Kennichi Kakudo, Thomas J. Giordano, Venâncio Avancini Ferreira Alves, Elham Khanafshar, L. Sylvia, Adel K. El‐Naggar, William E. Gooding, Steven P. Hodak, Ricardo V. Lloyd, Guy Maytal, Özgür Mete, Marina N. Nikiforova, Vânia Nosé, Mauro Papotti, David Poller, Peter M. Sadow, Arthur S. Tischler, R. Michael Tuttle, Kathryn B. Wall, Virginia A. LiVolsi, Gregory W. Randolph, Ronald Ghossein - JAMA Oncology 2016 cited by 1,384

  3. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology

    Authors: David L. Steward, Sally E. Carty, Rebecca S. Sippel, Samantha Peiling Yang, Julie Ann Sosa, Jennifer A. Sipos, James Figge, Susan J. Mandel, Bryan R. Haugen, Kenneth D. Burman, Zubair Baloch, Ricardo V. Lloyd, Raja R. Seethala, William E. Gooding, Simion I. Chiosea, Cristiane Gomes-Lima, Robert L. Ferris, Jessica M. Folek, Raheela Khawaja, Priya Kundra, Kwok Seng Loh, Carrie B. Marshall, Sarah E. Mayson, Kelly L. McCoy, Min En Nga, Kee Yuan Ngiam, Marina N. Nikiforova, Jennifer L. Poehls, Matthew D. Ringel, Huaitao Yang, Linwah Yip, Yuri E. Nikiforov - JAMA Oncology 2018 cited by 464

  4. PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

    Authors: Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava, Hyun-Bae Jie, Gulidanna Shayan, Yu L. Lei, Jessica Moskovitz, Jennifer Moy, Jing Li, Sven Brandau, Stephan Lang, Nicole C. Schmitt, Gordon J. Freeman, William E. Gooding, D.A. Clump, Robert L. Ferris - Cancer Research 2017 cited by 252

  5. First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy

    Authors: Malabika Sen, Sufi M. Thomas, Seungwon Kim, Joanne I. Yeh, Robert L. Ferris, Jonas T. Johnson, Umamaheswar Duvvuri, Jessica Lee, Nivedita Sahu, Sonali Joyce, Maria L. Freilino, Haibin Shi, Changyou Li, Danith H. Ly, Srinivas Rapireddy, Jonathan P. Etter, Pui‐Kai Li, Lin Wang, Simion I. Chiosea, Raja R. Seethala, William E. Gooding, Xiaomin Chen, Naftali Kaminski, Kusum Pandit, Daniel E. Johnson, Jennifer R. Grandis - Cancer Discovery 2012 cited by 309

  6. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

    Authors: Marina N. Nikiforova, Stephanie Mercurio, Abigail I. Wald, Michelle Barbi de Moura, Keith M. Callenberg, Lucas Santana‐Santos, William E. Gooding, Linwah Yip, Robert L. Ferris, Yuri E. Nikiforov - Cancer 2018 cited by 391

  7. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

    Authors: Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni, William E. Gooding, James Ohr, D.A. Clump, Julie E. Bauman, Robert L. Ferris, Theresa L. Whiteside - OncoImmunology 2019 cited by 168

  8. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets

    Authors: Laurent Müller, Masato Mitsuhashi, Patricia Simms, William E. Gooding, Theresa L. Whiteside - Scientific Reports 2016 cited by 308

  9. A Unique Subset of CD4+CD25highFoxp3+ T Cells Secreting Interleukin-10 and Transforming Growth Factor-β1 Mediates Suppression in the Tumor Microenvironment

    Authors: Laura Strauss, Christoph Bergmann, Mirosław J. Szczepański, William E. Gooding, Jonas T. Johnson, Theresa L. Whiteside - Clinical Cancer Research 2007 cited by 442

  10. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.

    Authors: Thomas K. Hoffmann, Grzegorz Dworacki, Takashi Tsukihiro, Norbert Meidenbauer, William E. Gooding, Jonas T. Johnson, Theresa L. Whiteside - 2002 cited by 388

  11. Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients

    Authors: Raghvendra M. Srivastava, Steve Lee, Pedro A. Andrade Filho, Christopher A. Lord, Hyun-Bae Jie, H. Carter Davidson, Andrés López‐Albaitero, Sandra P. Gibson, William E. Gooding, Soldano Ferrone, Robert L. Ferris - Clinical Cancer Research 2013 cited by 312

  12. Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study

    Authors: Linwah Yip, William E. Gooding, Alyaksandr V. Nikitski, Abigail I. Wald, Sally E. Carty, Esra Karslioglu French, Raja R. Seethala, Dan P. Zandberg, Robert L. Ferris, Marina N. Nikiforova, Yuri E. Nikiforov - Cancer 2021 cited by 75

  13. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

    Authors: Jennifer R. Grandis, Mona F. Melhem, William E. Gooding, Roger Day, Valerie A. Holst, Marilyn M. Wagener, Stephanie D. Drenning, David J. Tweardy - JNCI Journal of the National Cancer Institute 1998 cited by 1,109

  14. Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer

    Authors: Patrick J. Schuler, Malgorzata Harasymczuk, Carmen Visús, Albert B. DeLeo, Sumita Trivedi, Yu L. Lei, Athanassios Argiris, William E. Gooding, Lisa H. Butterfield, Theresa L. Whiteside, Robert L. Ferris - Clinical Cancer Research 2014 cited by 149

  15. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma

    Authors: Matthew L. Hedberg, Gerald Goh, Simion I. Chiosea, Julie E. Bauman, Maria L. Freilino, Yan Zeng, Lin Wang, Brenda Diergaarde, William E. Gooding, Vivian Wai Yan Lui, Roy S. Herbst, Richard P. Lifton, Jennifer R. Grandis - Journal of Clinical Investigation 2015 cited by 201

  16. Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database

    Authors: Taofeek K. Owonikoko, Camille Ragin, Chandra P. Belani, Ana B. Oton, William E. Gooding, Emanuela Taioli, Suresh S. Ramalingam - Journal of Clinical Oncology 2007 cited by 570

  17. Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome

    Authors: Markus Meißner, Torsten E. Reichert, Martin Kunkel, William E. Gooding, Theresa L. Whiteside, Soldano Ferrone, Barbara Seliger - Clinical Cancer Research 2005 cited by 267

  18. Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).

    Authors: Robert L. Ferris, William E. Gooding, Simion I. Chiosea, Umamaheswar Duvvuri, Seungwon Kim, Mark Kubik, Shaum Sridharan, Moon J. Fenton, Heath D. Skinner, Zahra Kelly, Housaiyin Li, Lazar Vujanović, Dan P. Zandberg - Journal of Clinical Oncology 2023 cited by 17

  19. Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer

    Authors: Robert L. Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T. Ruffin, Carly Reeder, James Ohr, William E. Gooding, Seungwon Kim, Brian J Karlovits, Dario A.A. Vignali, Umamaheswar Duvvuri, Jonas T. Johnson, Daniel P. Petro, Dwight E. Heron, David A. Clump, Tullia C. Bruno, Julie E. Bauman - Clinical Cancer Research 2022 cited by 32

  20. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

    Authors: Yuri E. Nikiforov, Sally E. Carty, Simion I. Chiosea, Christopher J. Coyne, Umamaheswar Duvvuri, Robert L. Ferris, William E. Gooding, Steven P. Hodak, Shane O. LeBeau, N. Paul Ohori, Raja R. Seethala, Mitchell Tublin, Linwah Yip, Marina N. Nikiforova - Cancer 2014 cited by 499

  21. Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases

    Authors: Rajesh Ramanathan, Haroon A. Choudry, Heather Jones, Mark D. Girgis, William E. Gooding, Paweł Kaliński, David L. Bartlett - Annals of Surgical Oncology 2021 cited by 27

  22. Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

    Authors: John C. Sok, Francesca M Coppelli, Sufi M. Thomas, Miriam N. Lango, Sichuan Xi, Jennifer L. Hunt, Maria L. Freilino, Michael W. Graner, Carol J. Wikstrand, Darell D. Bigner, William E. Gooding, Frank B. Furnari, Jennifer R. Grandis - Clinical Cancer Research 2006 cited by 490

  23. Extracapsular spread in head and neck carcinoma: Impact of site and human papillomavirus status

    Authors: Jessica H. Maxwell, Robert L. Ferris, William E. Gooding, Diana E. Cunningham, Vikas Mehta, Seungwon Kim, Eugene N. Myers, Jonas T. Johnson, Simion I. Chiosea - Cancer 2013 cited by 180

  24. Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

    Authors: Malabika Sen, Sonali Joyce, Mary Panahandeh, Changyou Li, Sufi M. Thomas, Jessica H. Maxwell, Lin Wang, William E. Gooding, Daniel E. Johnson, Jennifer R. Grandis - Clinical Cancer Research 2012 cited by 160